I was hoping for a follow up with today's trading and wonder what happened to the buyer(s) who traded 400,000 shares yesterday. Today M.M. took over with the scant 8k shares traded and lowered the ask from .32 to .315 to .3 and finally .29, putting large blocks with each of the asks. For some strange reason there were no takers today. Well tomorrow is another day. Let's see what is in store for we believers.
Just bizarre trading here. Yesterday almost 400k traded; up 5 cents; almost 20%. Today down 5 cents on less that 8 thousand shares. This dysfunctional trading is emblematic of our non performing BOD and CEO.
And shop still closed. Is this anyway to run a company???????? Wake up Ma, Leiberman, and Castle; our 3 stooges.
Press release below from march on MobiCare. Maybe available in US soon?
The MobiCare prototypes were first exhibited in November 2013 at CMEF Autumn 2013 in Xiamen, China and at MEDICA 2013 in Dusseldorf, Germany, and then at Arab Health 2014 in Dubai, UAE in January 2014. Based on the positive feedback from attendees at these events, the Company is preparing applications for CE marking and US FDA clearance
I have been noticing the accumulation of shares for the last couple of weeks and today's trading in the afternoon justified that accumulation. Something is going on and we shareholders will be the last to know. I'm looking forward to tomorrow's trading. A follow through with high volume would be nice.
In a 15 minute period, about 150k shares bought. If vaso really can get KPMG on board, it would give them instant credibility. Accounting for revenues has been a silent problem here for years and has been the main reason we have had zero following by the Street or Institutions. Vaso could get some real coverage with KPMG blessing financials.
Some would say we have what we deserve for beleiving in BS.
this is a useful medical device which has improved lives through increased endothelial function but we have found no one willing to bypass the resistant medical providers and so- called management is unwilling or unable to find a good salesman to bypass medical community and go straight to consumer.
i agree to a certain extent. the release no their blog by the Montreal entity is actually rather positive and has some potentially serious implications that were all but ignored and certainly not exploited by the company.
in large part- the group is looking into this due to the Euro reclassification. this is significant as was the original Euro announcement last Aug/Sept that really started the advance in to 4Q13 expectations. however, the company repeatedly refused to capitalize on the news/opportunity and even though investors game them two chances to restructure the communication and address - they failed and continue to do so.
that type of news should have a specific PR issued with it - not buried in an obscure company blog that few investors read (even long term ones that believe in the therapy). it should be conjoined with a PR stating what the study is looking to accomplish, the drivers behind the study (specifically highlighting the Euro approval), and conclude that the world body is slowly but specifically accepting EECP is viable due to the financial component tied to the efficacy results. THAT provides visibility and generates enthusiasm/interest. obscure blog posts DO NOT.
again, i believe the current increase is simply selling subsiding and not tied to any speculation on "news"
We just need some news to continue advance. And since this company never feels the need to for transparency, and all have zero expectations of management, a positive PR would be very unexpected and would cause a sharp spike in shares. It has always been so with vaso. Long periods of nothing interrupted by news related spikes.
like what...? based on trading and volume it looks like nothing more than what ever large sellers existed their supply has been exhausted or they have paused their selling. the resulting floor gave confidence to buyers who started stepping up and now are getting more confident that the price will reverse and start moving up from an oversold position.
problem is that the majority of the buying over the last couple of months are probably not going to be very closely held shares and will increase volatility on the way back up making it more difficult to reach past highs or higher floors.
i am not bemoaning the rise/reversal but the trading mechanics will make it significantly more difficult to sustain higher prices in the absence of NEW and long term holders.